Black Diamond Therapeutics, Inc. (BDTX) › RevenueBlack Diamond Therapeutics, Inc. (BDTX) — RevenueAnnual figures by fiscal year, from SEC filings.2024: $02025: $70.00M$70.00M2024Revenue (USD)2025Fiscal YearRevenueChange YoY2025$70.00M—2024$0—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share